1997
DOI: 10.1002/(sici)1097-0290(19970320)53:6<575::aid-bit5>3.0.co;2-j
|View full text |Cite
|
Sign up to set email alerts
|

Process simulation for recombinant protein production: Cost estimation and sensitivity analysis for heparinase I expressed inEscherichia coli

Abstract: Heparinase I from flavobacterium heparinum has several potential clinical applications; the resulting high demands on protein purity and quantity can be met by recombinant expression in Escherichia coli. Based on laboratory scale experiments with insoluble heparinase I expression followed by renaturation, a process for production of 3 kg/year of heparinase I was designed. We present a comparative analysis of the production costs of soluble and insoluble heparinase I expression, as well as a generalized approac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0
2

Year Published

2002
2002
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(17 citation statements)
references
References 17 publications
0
15
0
2
Order By: Relevance
“…In particular, substantial resources are applied to the development of recombinant protein production with P. pastoris (Calik et al 2015), the most widely used system as expression system for heterologous protein production (Gasser et al 2013). Purification of recombinant proteins, including cell lysis is commonly recognized among the most costly parts of entire production processes (Ernst et al 1997). Additionally, the cells are disrupted frequently under harsh conditions that can affect the product quality.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, substantial resources are applied to the development of recombinant protein production with P. pastoris (Calik et al 2015), the most widely used system as expression system for heterologous protein production (Gasser et al 2013). Purification of recombinant proteins, including cell lysis is commonly recognized among the most costly parts of entire production processes (Ernst et al 1997). Additionally, the cells are disrupted frequently under harsh conditions that can affect the product quality.…”
Section: Discussionmentioning
confidence: 99%
“…Table 1 also shows the estimated cost for the production of 1 mg IFN-α2b using E. coli fermentation and transgenic tobacco plant systems. Production of IFN-α2b using E. coli is calculated based on two different working volumes of bioreactor (2.9 m 3 and 36.2 m 3 ) according to the method of Ernst et al [41]. Production of IFN-α2b using transgenic plants, however, is calculated based on Burley tobacco using the method of Foreman [42].…”
Section: Discussionmentioning
confidence: 99%
“…The ChnA and ChnB expression levels reached approximately 3.5 and 3.7%, in strains FIBX6 and FIBX7 grown in heparin-only medium, respectively. In E. coli, the recombinant HepI level reached 250 mg/liter when expressed as inclusion bodies or 150 mg/liter in a soluble form in a small-scale fermentation setting (5). In a 3-day FIBX5 fermentation, the productivity of HepI averaged 500 mg/liter but could reach a much higher level when the fermentation time was extended (B. Eggimann and H. Su, personal communication).…”
Section: Discussionmentioning
confidence: 99%